0001610717-24-000040.txt : 20240124
0001610717-24-000040.hdr.sgml : 20240124
20240124161233
ACCESSION NUMBER: 0001610717-24-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cislini Jeff
CENTRAL INDEX KEY: 0001969082
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39219
FILM NUMBER: 24556534
MAIL ADDRESS:
STREET 1: C/O REVOLUTION MEDICINES, INC.
STREET 2: 700 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revolution Medicines, Inc.
CENTRAL INDEX KEY: 0001628171
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472029180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 415-766-3638
MAIL ADDRESS:
STREET 1: 700 SAGINAW DR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
form4.xml
X0508
4
2024-01-22
0001628171
Revolution Medicines, Inc.
RVMD
0001969082
Cislini Jeff
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY
CA
94063
true
General Counsel
true
Common Stock
2024-01-22
4
S
0
1500
27
D
36126
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2023.
Includes 31,417 restricted stock units.
Includes 342 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023.
/s/ Jack Anders, as Attorney-in-fact for Jeff Cislini
2024-01-24